Evolving and evaluating the OMERACT fellows program: insights and implications from OMERACT 2023 fellows

Chapman, Lara S., Kelly, Ayano, Balay-Dustrude, Erin, Bekker, Charlotte, Berthelsen, Dorthe B., Ghosh, Nilasha, Gordon, Rachael A., Haas, Romi, Jones, Caitlin, Luquini, Andre, Weinbrecht-Mischkewitz, Max, Pickles, Tim ORCID: https://orcid.org/0000-0001-7743-0234, Saygin, Didem, Nielsen, Wils, Webers, Casper, Grosskleg, Shawna, Tugwell, Peter, D'Agostino, Maria Antonietta, Guillemin, Francis and March, Lyn 2024. Evolving and evaluating the OMERACT fellows program: insights and implications from OMERACT 2023 fellows. Seminars in Arthritis and Rheumatism 65 , 152391. 10.1016/j.semarthrit.2024.152391

Preview

PDF - Published Version Available under License Creative Commons Attribution. Download (3MB) | Preview

Abstract

Objective: To describe the evolution of the OMERACT Fellows Program (OM FP) and to evaluate the innovative changes implemented in the 2023 program. Methods: The OM FP, the first of its kind in global rheumatology, was developed in 2000 to mentor early career researchers in methods and processes for reaching evidence-driven consensus for outcome measures in clinical studies. The OM FP has evolved through continuing iterations of face to face and online feedback. Key new features delivered in 2023 included e-learning modules, virtual introductory pre-meetings, increased networking with Patient Research Partners (PRPs), learning opportunities to give and receive personal feedback, ongoing performance feedback during the meeting from Fellow peers, PRPs, senior OMERACTers (members of the OMERACT community) and Emerging Leader mentors, involvement in pitching promotions, two-minute Lightning Talks in a plenary session and an embedded poster tour. An online survey was distributed after the meeting to evaluate the program. Results: OM FP has included 208 fellows from 16 countries across 4 continents covering 47 different aspects of rheumatology outcomes since its inception. Over 50 % have remained engaged with OMERACT work. In 2023, 18 Fellows attended and 15 (83 %) completed the post-meeting survey. A dedicated OM FP was deemed important by all respondents, and 93 % would attend the meeting in future. The PRP/Fellow Connection Carousel and Lightning Talks were rated exceptional by 93 %. Key components to improve included clarification of expectations, overall workload, the Emerging Leaders Mentoring Program, and the content and duration of daily summary sessions. Conclusion: The innovations in the 2023 OM FP were well received by the majority of participants and supports early career rheumatology researchers to develop collaborations, skills and expertise in outcome measurement. Implementation of feedback from Fellows will enhance the program for future meetings, continuing to facilitate learning and succession planning within OMERACT.

Item Type:	Article
Date Type:	Publication
Status:	Published
Schools:	Medicine Centre for Trials Research (CNTRR)
Publisher:	Elsevier
ISSN:	0049-0172
Date of First Compliant Deposit:	28 March 2024
Date of Acceptance:	4 February 2024
Last Modified:	02 Apr 2024 11:00
URI:	https://orca.cardiff.ac.uk/id/eprint/167599

Actions (repository staff only)

Edit Item